{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:56:04Z","timestamp":1789703764187,"version":"4.0.1"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,3,7]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Neonatal sepsis is a leading cause of neonatal mortality. New interventions are needed to decrease neonatal sepsis and mortality in regions with highest burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy of intrapartum azithromycin to reduce neonatal sepsis or mortality, as well as neonatal and maternal infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This double-blind, placebo-controlled, randomized clinical trial enrolled and followed up birthing parents and their infants at 10 health facilities in The Gambia and Burkina Faso, West Africa, between October 2017 and May 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants were assigned at random to receive oral azithromycin (2 g) or placebo (ratio 1:1) during labor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was a composite of neonatal sepsis or mortality, with the former defined based on microbiologic or clinical criteria. Secondary outcomes were neonatal infections (skin, umbilical, eye and ear infections), malaria, and fever; postpartum infections (puerperal sepsis, mastitis), fever, and malaria; and use of antibiotics during 4-week follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The trial randomized 11\u202f983 persons in labor (median age, 29.9 years). Overall, 225 newborns (1.9% of 11\u202f783 live births) met the primary end point. The incidence of neonatal mortality or sepsis was similar in the azithromycin and placebo groups (2.0% [115\/5889] vs 1.9% [110\/5894]; risk difference [RD], 0.09 [95% CI, \u22120.39 to 0.57]), as was the incidence of neonatal mortality (0.8% vs 0.8%; RD, 0.04 [95% CI, \u22120.27 to 0.35]) and neonatal sepsis (1.3% vs 1.3%; RD, 0.02 [95% CI, \u22120.38 to 0.43]). Newborns in the azithromycin group compared with the placebo group had lower incidence of skin infections (0.8% vs 1.7%; RD, \u22120.90 [95% CI, \u22121.30 to \u22120.49]) and need for antibiotics (6.2% vs 7.8%; RD, \u22121.58 [95% CI, \u22122.49 to \u22120.67]). Postpartum parents in the azithromycin group had lower incidence of mastitis (0.3% vs 0.5%; RD, \u22120.24 [95% CI, \u22120.47 to \u22120.01]) and puerperal fever (0.1% vs 0.3%; RD, \u22120.19 [95% CI, \u22120.36 to \u22120.01]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Azithromycin administered orally during labor did not reduce neonatal sepsis or mortality. These results do not support routine introduction of oral intrapartum azithromycin for this purpose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03199547\">NCT03199547<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2022.24388","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T11:31:45Z","timestamp":1678188705000},"page":"716","source":"Crossref","is-referenced-by-count":58,"title":["Effect of Intrapartum Azithromycin vs Placebo on Neonatal Sepsis and Death"],"prefix":"10.1001","volume":"329","author":[{"given":"Anna","family":"Roca","sequence":"first","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bully","family":"Camara","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Bognini","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman N.","family":"Nakakana","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athasana M.","family":"Som\u00e9","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Beloum","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toussaint","family":"Rouamba","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatoumata","family":"Sillah","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madikoi","family":"Danso","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joquina C.","family":"Jones","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashu","family":"Graves","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isatou","family":"Jagne","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Getanda","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saffiatou","family":"Darboe","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C.","family":"Tahita","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Ndure","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien S.","family":"Franck","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawadogo Y.","family":"Edmond","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai L.","family":"Dondeh","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried G. J.","family":"Nassa","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Garba","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulie","family":"Bojang","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusupha","family":"Njie","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bottomley","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halidou","family":"Tinto","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences de la Sant\u00e9\u2013Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PregnAnZI-2 Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousman","family":"Secka","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edrissa","family":"Sabally","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siaka","family":"Badjie","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar B.","family":"Jarra","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulayman","family":"Bah","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulie","family":"Suso","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakary","family":"Fatty","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson","family":"Lush","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asheme","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momodou","family":"Barry","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sambou","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kady","family":"Kassibo","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Haffner","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamin","family":"Bojang","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebba","family":"Manneh","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momodou Lamin","family":"Waggeh","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lankoand\u00e9","family":"Diagniagou","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karama","family":"Ibrahima","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonli Lan-Boado","family":"Rodrigue","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millogo Ou\u00e9dalo","family":"Nad\u00e8ge","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aboubakary","family":"Sourabi\u00e9","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chandramohan","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Blencowe","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ashorn","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Quigley","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Schrag","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Solomon","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Oluwalana","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kabor\u00e9","sequence":"additional","affiliation":[{"name":"for the PregnAnZI-2 Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9938","key":"joi220150r1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0140-6736(14)60496-7","article-title":"Every newborn: progress, priorities, and potential beyond survival.","volume":"384","author":"Lawn","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"joi220150r2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1473-3099(09)70172-0","article-title":"Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa.","volume":"9","author":"Seale","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"joi220150r3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S1473-3099(19)30414-1","article-title":"Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines.","volume":"19","author":"Okomo","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"10303","key":"joi220150r4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0140-6736(21)01207-1","article-title":"Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.","volume":"398","author":"Collaborators","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"joi220150r5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/phar.1992.12.issue-3","article-title":"Azithromycin: spectrum of activity, pharmacokinetics, and clinical applications.","volume":"12","author":"Drew","year":"1992","journal-title":"Pharmacotherapy"},{"issue":"9","key":"joi220150r6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2009.1266","article-title":"Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.","volume":"302","author":"Porco","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"joi220150r7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/clinids\/24.3.356","article-title":"A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.","volume":"24","author":"Leach","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"11","key":"joi220150r8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000861","article-title":"Trachoma prevalence and associated risk factors in The Gambia and Tanzania: baseline results of a cluster randomised controlled trial.","volume":"4","author":"Harding-Esch","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"joi220150r9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1086\/cid.2002.35.issue-4","article-title":"Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.","volume":"35","author":"Fry","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"17","key":"joi220150r10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","article-title":"Azithromycin to reduce childhood mortality in sub-Saharan Africa.","volume":"378","author":"Keenan","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"joi220150r11","doi-asserted-by":"publisher","first-page":"565.e1","DOI":"10.1016\/j.cmi.2016.03.005","article-title":"Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial.","volume":"22","author":"Roca","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"joi220150r12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2281","article-title":"Azithromycin in labor lowers clinical infections in mothers and newborns: a double-blind trial.","volume":"139","author":"Oluwalana","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"joi220150r13","doi-asserted-by":"publisher","DOI":"10.18203\/2349-3259.ijct20220110","article-title":"Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase III double-blind randomized clinical trial (PregnAnZI-2 trial).","volume":"9","author":"Camara","year":"2022","journal-title":"Int J Clin Trials"},{"key":"joi220150r15","doi-asserted-by":"publisher","first-page":"25368","DOI":"10.3402\/gha.v7.25368","article-title":"Pregnancy-related mortality in Africa and Asia: evidence from INDEPTH Health and Demographic Surveillance System sites.","volume":"7","author":"Streatfield","year":"2014","journal-title":"Glob Health Action"},{"issue":"9705","key":"joi220150r16","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(09)61339-8","article-title":"Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial.","volume":"374","author":"Cutland","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"joi220150r17","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100054","article-title":"Neonatal azithromycin administration for prevention of infant mortality.","volume":"1","author":"Oldenburg","year":"2022","journal-title":"NEJM Evid"},{"issue":"10063","key":"joi220150r18","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals.","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"23","key":"joi220150r19","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1056\/NEJMoa1811400","article-title":"Effect of adding azithromycin to seasonal malaria chemoprevention.","volume":"380","author":"Chandramohan","year":"2019","journal-title":"N Engl J Med"},{"issue":"13","key":"joi220150r21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa1602044","article-title":"Adjunctive azithromycin prophylaxis for cesarean delivery.","volume":"375","author":"Tita","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"joi220150r22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/AOG.0000000000004565","article-title":"Single dose of oral azithromycin with or without amoxicillin to prevent peripartum infection in laboring, high-risk women in Cameroon: a randomized controlled trial.","volume":"138","author":"Subramaniam","year":"2021","journal-title":"Obstet Gynecol"},{"key":"joi220150r14","unstructured":"Burkina Faso CNdlS. Minist\u00e8re de la Sant\u00e9 et de l\u2019Hygi\u00e8ne Publique. Accessed September 21, 2022. https:\/\/www.sante.gov.bf\/"},{"key":"joi220150r20","unstructured":"Healthy Newborn Network. Accessed September 21, 2022. https:\/\/www.healthynewbornnetwork.org\/"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2802062\/jama_roca_2023_oi_220150_1677717771.34793.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T11:31:47Z","timestamp":1678188707000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2802062"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,3,7]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.24388","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,7]]}}}